Literature DB >> 18544791

Caution about Newcastle disease virus-based live attenuated vaccine.

Guan-Zhu Han, Xi-Ping Liu, Si-Shen Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18544791      PMCID： PMC2447105          DOI： 10.1128/JVI.00370-08

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  10 in total

1.  Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses.

Authors:  Elizabeth R Chare; Ernest A Gould; Edward C Holmes
Journal:  J Gen Virol       Date:  2003-10       Impact factor: 3.891

Review 2.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

3.  Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Authors:  Luis Martinez-Sobrido; Negin Gitiban; Ana Fernandez-Sesma; Jerome Cros; Sara E Mertz; Nancy A Jewell; Sue Hammond; Emilio Flano; Russell K Durbin; Adolfo García-Sastre; Joan E Durbin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

Authors:  Jinying Ge; Guohua Deng; Zhiyuan Wen; Guobing Tian; Yong Wang; Jianzhong Shi; Xijun Wang; Yanbing Li; Sen Hu; Yongping Jiang; Chinglai Yang; Kangzhen Yu; Zhigao Bu; Hualan Chen
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

5.  Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.

Authors:  Joshua M DiNapoli; Lijuan Yang; Amorsolo Suguitan; Subbiah Elankumaran; David W Dorward; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

6.  Pathogen evolution and disease emergence in carnivores.

Authors:  Alex J McCarthy; Marie-Anne Shaw; Simon J Goodman
Journal:  Proc Biol Sci       Date:  2007-12-22       Impact factor: 5.349

7.  Identification of a natural multi-recombinant of Newcastle disease virus.

Authors:  Guan-Zhu Han; Cheng-Qiang He; Nai-Zheng Ding; Le-Yuan Ma
Journal:  Virology       Date:  2007-10-29       Impact factor: 3.616

8.  F gene recombination between genotype II and VII Newcastle disease virus.

Authors:  Zhuoming Qin; Lei Sun; Baochen Ma; Zhizhong Cui; Yiping Zhu; Yoshihiro Kitamura; Wenjun Liu
Journal:  Virus Res       Date:  2007-11-19       Impact factor: 3.303

9.  Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants.

Authors:  Tatiana J Wittmann; Roman Biek; Alexandre Hassanin; Pierre Rouquet; Patricia Reed; Philippe Yaba; Xavier Pourrut; Leslie A Real; Jean-Paul Gonzalez; Eric M Leroy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  Evidence of recombination among early-vaccination era measles virus strains.

Authors:  Mikkel H Schierup; Carl H Mordhorst; Claude P Muller; Laurids S Christensen
Journal:  BMC Evol Biol       Date:  2005-10-06       Impact factor: 3.260
  10 in total
  8 in total

1.  What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?

Authors:  Peter L Collins; Alexander Bukreyev; Brian R Murphy
Journal:  J Virol       Date:  2008-10       Impact factor: 5.103

2.  Not so fast on recombination analysis of Newcastle disease virus.

Authors:  Claudio L Afonso
Journal:  J Virol       Date:  2008-09       Impact factor: 5.103

Review 3.  Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.

Authors:  Aseem Pandey; Neetu Singh; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Hum Vaccin       Date:  2010-02-24

Review 4.  Homologous recombination in negative sense RNA viruses.

Authors:  Guan-Zhu Han; Michael Worobey
Journal:  Viruses       Date:  2011-08-04       Impact factor: 5.048

5.  Analysis and insights into recombination signals in lumpy skin disease virus recovered in the field.

Authors:  Alexander Sprygin; Yurii Babin; Yana Pestova; Svetlana Kononova; David B Wallace; Antoinette Van Schalkwyk; Olga Byadovskaya; Vyacheslav Diev; Dmitry Lozovoy; Alexander Kononov
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 6.  Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human.

Authors:  Julianne Vilela; Mohammed A Rohaim; Muhammad Munir
Journal:  Vaccines (Basel)       Date:  2022-02-08

7.  Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.

Authors:  Dong-Hun Lee; Jae-Keun Park; Jung-Hoon Kwon; Seong-Su Yuk; Tseren-Ochir Erdene-Ochir; Yo-Han Jang; Baik-Lin Seong; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

Review 8.  Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.

Authors:  Richard C Condit; Anna-Lise Williamson; Rebecca Sheets; Stephen J Seligman; Thomas P Monath; Jean-Louis Excler; Marc Gurwith; Karin Bok; James S Robertson; Denny Kim; R Michael Hendry; Vidisha Singh; Lisa M Mac; Robert T Chen
Journal:  Vaccine       Date:  2016-06-23       Impact factor: 3.641
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.